 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Syros Pharmaceuticals Inc. (SYRS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-11 Purchase | 2019-11-12 4:34 pm | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 20,000 | $4.98 | $99,596 | 35,000 (Direct) | View |
| 2019-08-15 Sale | 2019-08-19 4:08 pm | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 25,000 | $10 | $250,000 | 417,801 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 7:26 pm | Syros Pharmaceuticals Inc. | SYRS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 63,000 | $7.766 | $489,280 | 4,302,051 (Direct) | View |
| 2019-04-09 Purchase | 2019-04-11 4:37 pm | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 533,332 | $7.5 | $3,999,990 | 1,593,270 (Indirect) | View |
| 2019-03-12 Sale | 2019-03-14 6:57 pm | Syros Pharmaceuticals Inc. | SYRS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 167,503 | $7.835 | $1,312,380 | 4,432,462 (Direct) | View |
| 2019-03-07 Sale | 2019-03-11 5:58 pm | Syros Pharmaceuticals Inc. | SYRS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 164,583 | $6.797 | $1,118,649 | 4,601,928 (Direct) | View |
| 2018-01-31 Purchase | 2018-02-02 3:53 pm | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 209,424 | $9.55 | $1,999,999 | 1,059,938 (Indirect) | View |
| 2017-12-15 Purchase | 2017-12-15 4:02 pm | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 15,000 | $9.084 | $136,260 | 15,000 (Direct) | View |
| 2017-12-12 Purchase | 2017-12-14 8:22 pm | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 109,774 | $9.033 | $991,558 | 830,494 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-11 Option Award | 2019-06-12 4:18 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:17 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:17 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | Shaw Alice Tsang Director | 22,000 | $5.6 | 22,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:16 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | SHARP PHILIP A Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:16 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | SATO VICKI L Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:15 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:15 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:14 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | BONNEY MICHAEL W Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:14 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 11,000 | $5.6 | 11,000 (Direct) | View |
| 2019-04-09 Purchase | 2019-04-11 4:37 pm | 2019-04-09 2022-10-10 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 133,333 | $8.625 | 1,593,270 (Indirect) | View |
| 2019-02-12 Option Award | 2019-02-14 5:19 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 87,000 | $0 | 102,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:19 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer | 75,000 | $6.71 | 102,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:19 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 188,000 | $0 | 669,288 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:19 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 285,000 | $6.71 | 669,288 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:18 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 87,000 | $0 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:18 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 75,000 | $6.71 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:18 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E CAO | 87,000 | $0 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:18 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E CAO | 75,000 | $6.71 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:17 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 87,000 | $0 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:17 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 75,000 | $6.71 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:17 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr CFO | 87,000 | $0 | 87,000 (Direct) | View |
| 2019-02-12 Option Award | 2019-02-14 5:17 pm | N/A 2029-02-11 | Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr CFO | 75,000 | $6.71 | 87,000 (Direct) | View |
| 2018-11-29 Exercise | 2018-12-03 4:06 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 98,504 | $1.01 | 872,657 (Direct) | View |
| 2018-11-29 Exercise | 2018-12-03 4:06 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 12,084 | $3.04 | 872,657 (Direct) | View |
| 2018-11-29 Exercise | 2018-12-03 4:06 pm | N/A 2023-05-21 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 23,454 | $1.01 | 872,657 (Direct) | View |
| 2018-11-29 Exercise | 2018-12-03 4:06 pm | N/A 2023-05-21 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 75,050 | $1.01 | 872,657 (Direct) | View |
| 2018-11-29 Exercise | 2018-12-03 4:06 pm | N/A 2024-10-21 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 12,084 | $3.04 | 872,657 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:30 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:30 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:29 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | SHARP PHILIP A Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:29 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | SATO VICKI L Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:29 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:28 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:28 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | BONNEY MICHAEL W Director | 13,000 | $12.95 | 13,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-15 4:24 pm | N/A 2028-06-13 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 11,000 | $12.95 | 11,000 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-12 5:10 pm | N/A 2028-03-11 | Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr CFO | 150,000 | $12.32 | 150,000 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-12 5:10 pm | N/A 2028-03-11 | Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr CFO | 50,000 | $12.32 | 150,000 (Direct) | View |
| 2018-02-16 Option Award | 2018-02-21 4:09 pm | N/A 2028-02-15 | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer | 75,000 | $10.09 | 75,000 (Direct) | View |
| 2018-02-16 Option Award | 2018-02-21 4:09 pm | 2018-02-16 2026-09-26 | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer | 11,666 | $13.3 | 75,000 (Direct) | View |
| 2018-02-16 Option Award | 2018-02-21 4:08 pm | N/A 2028-02-15 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 75,000 | $10.09 | 75,000 (Direct) | View |
| 2018-02-16 Option Award | 2018-02-21 4:08 pm | N/A 2028-02-15 | Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer | 75,000 | $10.09 | 75,000 (Direct) | View |
| 2018-02-16 Option Award | 2018-02-21 4:08 pm | N/A 2028-02-15 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A CEO | 285,000 | $10.09 | 285,000 (Direct) | View |